Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils

Digestion

Volumn 74, Issue 3-4, 2007, Pages 187-198

  Futagami, Seiji ^a   Suzuki, Kenji ^a   Hiratsuka, Tetsuro ^a   Shindo, Tomotaka ^a   Hamamoto, Tatsuhiko ^a   Tatsuguchi, Atsushi ^a   Ueki, Nobue ^a   Shinji, Yoko ^a   Kusunoki, Masanori ^a   Wada, Ken ^a   Miyake, Kazumasa ^a   Gudis, Katya ^a   Tsukui, Taku ^a   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cdx2; COX 2 inhibitor; Gastric cancer; Helicobacter pylori; Metaplasia, intestinal

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; MUCIN 2; TRANSCRIPTION FACTOR CDX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRUCELLA; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; PRECANCEROUS CONDITIONS; PROBABILITY; PYRAZOLES; RANDOM ALLOCATION; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SULFONAMIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 34247199440     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100503     Document Type: Article

References (47)

1. Genta RM, Gurer IE, Graham DY, Krishman B, Segura AM, Gutierrez O, Kim JG, Burchette JL Jr: Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996;111:1206-1211.
2. Stemmermann GN: Intestinal metaplasia of the stomach. A status report. Cancer 1994; 74:556-564.
3. Mutoh H, Sakurai S, Satoh K, Osawa H, Hakamata Y, Takeuchi T, Sugano K: Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004;53: 1416-1423.
4. Mizoshita T, Inada K, Tsukamoto T, Kodera Y, Yamamura Y, Hirai T, Kato T, Joh T, Itoh M, Tatematsu M: Expression of CdX1 and CdX2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa-with special emphasis on participation in intestinal metaplasia of human stomach. Gastric Cancer 2001;4:185-191.
5. Almeida R, Silva E, Santos-Silva F, Silberg DG, Wang J, De Bolos C, David L: Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 2003; 199:36-40.
6. Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, Sackett SD, Kaestner KH: Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002;122:689-696.
7. Futagami S, Hiratsuka T, Tatsuguchi A, Suzuki K, Kusunoki M, Shinji Y, Shinoki K, Iizumi T, Akamatsu T, Nishigaki H, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C: MCP-1 released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells. Gut 2003;52:1257-1264.
8. Tatsuguchi A, Matsui K, Shinji Y, Gudis K, Tsukui T, Kishida T, Fukuda Y, Sugisaki Y, Tokunaga A, Tajiri T, Sakamoto C: Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol 2004;35:488-495.
9. Fu SL, Wu YL, Zhang YP, Qiao MM, Chen Y: Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol 2004;10:1971-1974.
10. Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD, Bai AH, Sung JJ: Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004;53:195-200.
11. Nam KT, Hahm KB, Oh SY, Yeo M, Han SU, Ahn B, Kim YB, Kang JS, Jang DD, Yang KH, Kim DY: The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori -associated gastric cancer development in a mouse model. Clin Cancer Res 2004;10: 8105-8113.
12. Kawamori T, Rao CV, Seibert K, Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58: 409-412.
13. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M: Helicobacter pylori infecton induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-648.
14. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M: Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999;20:669-676.
15. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M: Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbils. Cancer Res 1998;58:2067-2069.
16. Tatematsu M, Tsukamoto T, Mizoshita T: Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter 2005;10:97-106.
17. Roessler K, Monig SP, Schneider PM, Hanisch FG, Landsberg S, Thiele J, Holscher AH, Dienes HP, Baldus SE: Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. World J Gastroenterol 2005; 11:3182-3188.
18. Satoh K, Mutoh H, Eda A, Yanaka I, Osawa H, Honda S, Kawata H, Kihira K, Sugano K: Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori . Helicobacter 2002;7:192-198.
19. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M: Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997;112:387-397.
20. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20: 1161-1181.
21. Domon-Dell C, Wang Q, Kim S, Kedinger M, Evers BM, Freund JN: Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells. Gut 2002;50:525-529.
22. Futagami S, Hiratsuka T, Wada K, Tatsuguchi A, Tsukui T, Miyake K, Akamatsu T, Hosone M, Sakamoto C, Kobayashi M: Inhibition of Helicobacter pylori -induced cyclooxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils. Aliment Pharmacol Ther 2002;16:847-855.
23. Magari H, Shimizu Y, Inada K, Enomoto S, Tomeki T, Yanaoka K, Tamai H, Arii K, Nakata H, Oka M, Utsunomiya H, Tsutsumi Y, Tsukamoto T, Tatematsu M, Ichinose M: Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori -infected Mongolian gerbils. Biochem Biophys Res Commun 2005;334:606-612.
24. Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, Yoshida T, Ido K, Sugano K: Development of gastric carcinoma from intestinal metaplasia in CdX2-transgenic mice. Cancer Res 2004;64:7740-7747.
25. Eda A, Osawa H, Yanaka I, Satoh K, Mutoh H, Kihira K, Sugano K: Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 2002;37:94-100.
26. Kim S, Domon-Dell C, Wang Q, Chung DH, Di Cristofano A, Pandolfi PP, Freund JN, Evers BM: PTEN and TNF-α regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway. Gastroenterology 2002; 123:1163-1178.
27. Shishodia S, Koul D, Aggarwal BB: Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-κB activation through inhibition of activation of IκBα kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 2004;173:2011-2022.
28. Shishodia S, Aggarwal BB: Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-κB by suppressing activation of IκBα kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res 2004;64:5004-5012.
29. Reddy BS, Rao CV, Seibert K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996;56:4566-4569.
30. Niederberger E, Tegeder I, Vetter G, Schmidtko A, Schmidt H, Euchenhofer C, Brautigam L, Grosch S, Geisslinger G: Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-κB. FASEB J 2001; 15:1622-1624.
31. Wu T, Leng J, Han C, Demetris AJ: The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Mol Cancer Ther 2004;3:299-307.
32. Subhashini J, Mahipal SV, Reddanna P: Antiproliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Cancer Lett 2005;224:31-43.
33. Yang Y, Deng CS, Peng JZ, Wong BC, Lam SK, Xia HH: Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. J Clin Pathol 2003;56:19-24.
34. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
35. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T: Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18563-18569.
36. Williams CS, Tsujii M, Reese J, Dey SK, Du-Bois RN: Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105: 1589-1594.
37. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M: Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenograpfts via induction of apoptosis in nude mice. Am J Physiol Gastrointest Liver Physiol 1998;274: 1061-1067.
38. Nagata K, Wada K, Tatsuguchi A, Futagami S, Gudis K, Miyake K, Tsukui T, Sakamoto C: Heregulin-α and heregulin-β expression is linked to a COX-2-PGE2 pathway in human gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol 2006;290:G1243-G1251.
39. Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, Cardiff RD, Newman RA, Yang P, Thaler HT, Muller WJ, Hudis C, Brown AM, Hla T, Subbaramaiah K, Dannenberg AJ: HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res 2005; 65:10113-10119.
40. Takahashi M, Ota S, Hata Y, Mikami Y, Azuma N, Nakamura T, Terano A, Omata M: Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 1996;98:2604-2611.
41. Uesaka T, Lu H, Katoh O, Watanabe H: Heparin-binding EGF-like growth factor gene transcription regulated by Cdx2 in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 2002;283:840-847.
42. Nozaki K, Shimizu N, Tsukamoto T, Inada K, Cao X, Ikehara Y, Kaminishi M, Sugiyama A, Tatematsu M: Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication. Jpn J Cancer Res 2002;93: 374-381.
43. Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, Fox JG, Lee JR, Wang TC, Goldenring JR: Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis -infected mice. Gastroenterology 2004; 127:582-594.
44. Mitomi H, Iwabuchi K, Amemiya A, Kaneda G, Adachi K, Asao T: Immunohistochemical analysis of a case of gastritis cystica profunda associated with carcinoma development. Scand J Gastroenterol 1998;33:1226-1229.
45. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC: Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000;119:7-14.
46. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS, China Gastric Cancer Study Group: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. JAMA 2004;291:187-194.
47. Shimizu N, Ikehara Y, Inada K, Nakanishi H, Tsukamoto T, Nozaki K, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M: Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000;60: 1512-1514.